- Article Type
- Press Release
Case Study
Subscribe to RSS Feed
Celltrion launches world’s first biosimilar monoclonal antibody Remsima™ in 12 new European markets
UK, 25 Feb 2015 /- Hanover
Now available in 31 countries for the treatment of autoimmune diseases.
4th World Summit “Gut Microbiota For Health” to be held in Barcelona
Austria, 24 Feb 2015 /- Gut Microbiota and Health
World-leading experts meet in Barcelona, Spain, from 14 to 15 March 2015, to discuss the latest findings in gut microbiota research and their significance for...
Six posters on clinical experience with biosimilar mAb infliximab presented at European Crohn’s and Colitis Organisation (ECCO) 10th annual congress
UK, 20 Feb 2015 /- Hanover
20 February 2015, Barcelona, Spain, Celltrion Healthcare has today announced data demonstrating that the world’s first biosimilar monoclonal antibody (mAb)...
Data show the world’s first EMA-approved biosimilar monoclonal antibody Remsima™ could reduce cost of treating Crohn’s disease by up to €336 million over five years1
UK, 20 Feb 2015 /- Hanover
Cost savings could help improve patient access to life-changing treatment
The state of hospital pharmacy in Europe in 2015: EAHP opens new look practice survey!
Belgium, 10 Feb 2015 /- European Association of Hospital Pharmacists (EAHP)
In the run up to its annual Congress, the European Association of Hospital Pharmacists (EAHP) has issued a new format practice survey to heads of hospital...
HMRC benchmarking for Pharmacists
England, 13 Jan 2015 /- TWD Accountants Ltd
Benchmarking is a guide devised by HM Revenue & Customs (HMRC) so that you can compare your business performance with other businesses in the same trade sector.
EAHP’s New Year appeal to Europe: Make 2015 a year of action on antimicrobial resistance
Belgium, 08 Jan 2015 /- European Association of Hospital Pharmacists (EAHP)
At the start of the new European Commission’s first full year of operation, the European Association of Hospital Pharmacists (EAHP) has issued a call to EU...
Mundipharma receives positive CHMP opinion for oxycodone / naloxone combination for the treatment of restless legs syndrome1
Ireland, 25 Nov 2014 /- Mundipharma Pharmaceuticals Limited
Dublin, 25 November 2014 – Mundipharma recently announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)...
REPORT: Patients suffering from medicines shortages in all European countries
Belgium, 18 Nov 2014 /- European Association of Hospital Pharmacists (EAHP)
A new report on medicines shortages experienced in European healthcare systems reveals that over 86% of hospital pharmacists are experiencing difficulties in...
Key research from the inaugural 2014 palliative care in oncology symposium highlights advances in integrating palliative care into treatment and financial hardships facing people living with cancer
USA, 21 Oct 2014 /- American Society of Clinical Oncology (ASCO)
ALEXANDRIA, Va. – Four studies from the inaugural 2014 Palliative Care in Oncology Symposium were highlighted today in an embargoed presscast for reporters....
CTI and Independence Blue Cross study in Health Service Research finds fewer emergency room visits for chronically ill patients treated in patient-centered medical homes
USA, 09 Sep 2014 /- CTI Clinical Trial and Consulting Services
Largest study of its kind shows nearly an 8 percent reduction in emergency visits, primarily for those with diabetes, heart disease and high blood pressure
Is Europe putting cancer research at risk?
Switzerland, 25 Jul 2014 /- European Society for Medical Oncology (ESMO)
Lugano, Switzerland, 25 July 2014. The European Society for Medical Oncology (ESMO), the leading pan-European association representing medical oncology...
Tough decision for Roche following mixed Phase II Trial results for Alzheimer’s drug, says GlobalData Analyst
UK, 24 Jul 2014 /- GlobalData
• Roche faces difficult decision over entering Alzheimer’s disease (AD) drug crenezumab for Phase III clinical trials
EAHP: Apps involving medicines should have pharmacist oversight
Belgium, 08 Jul 2014 /- European Association of Hospital Pharmacists (EAHP)
The European Association of Hospital Pharmacists (EAHP) has responded to a consultation by the European Commission
Confident but not controlled: 92% of Irish people with asthma are confident about managing their condition however 48% are deemed ‘uncontrolled’1
Ireland, 30 Jun 2014 /- Mundipharma Pharmaceuticals Limited
Pan-European Survey reveals low levels of asthma control in Ireland
ESMO 16 World GI Press Release: International phase III trial shows survival benefit of MM-398 added to standard treatment in post-gemcitabine metastatic pancreatic cancer
Switzerland, 27 Jun 2014 /- European Society for Medical Oncology (ESMO)
Barcelona/Lugano -- Adding the novel MM-398 to standard treatment for metastatic pancreatic cancer patients who have already received gemcitabine improves...